Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: Is Real Circulating Tumor Cell Number Superior to Prostate-Specific Antigen?

Leggi l'articolo originale


Journal of Clinical Oncology, Ahead of Print.

Lascia un commento